These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33928585)

  • 1. siRNA Therapeutics for Protein Misfolding Diseases of the Central Nervous System.
    Zabel MD; Mollnow L; Bender H
    Methods Mol Biol; 2021; 2282():377-394. PubMed ID: 33928585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopeptide Delivery of siRNA to the Central Nervous System.
    Zabel MD; Mollnow L; Bender H
    Methods Mol Biol; 2019; 1943():389-403. PubMed ID: 30838631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopeptide delivery of siRNA to the central nervous system.
    Zabel MD
    Methods Mol Biol; 2013; 948():251-62. PubMed ID: 23070775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes.
    Bender HR; Kane S; Zabel MD
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-siRNA-peptide complexes cross the blood-brain barrier and significantly decrease PrP on neuronal cells and PrP in infected cell cultures.
    Pulford B; Reim N; Bell A; Veatch J; Forster G; Bender H; Meyerett C; Hafeman S; Michel B; Johnson T; Wyckoff AC; Miele G; Julius C; Kranich J; Schenkel A; Dow S; Zabel MD
    PLoS One; 2010 Jun; 5(6):e11085. PubMed ID: 20559428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PrPC knockdown by liposome-siRNA-peptide complexes (LSPCs) prolongs survival and normal behavior of prion-infected mice immunotolerant to treatment.
    Bender H; Noyes N; Annis JL; Hitpas A; Mollnow L; Croak K; Kane S; Wagner K; Dow S; Zabel M
    PLoS One; 2019; 14(7):e0219995. PubMed ID: 31329627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bridging small interfering RNA with giant therapeutic outcomes using nanometric liposomes.
    Singh Y; Tomar S; Khan S; Meher JG; Pawar VK; Raval K; Sharma K; Singh PK; Chaurasia M; Surendar Reddy B; Chourasia MK
    J Control Release; 2015 Dec; 220(Pt A):368-387. PubMed ID: 26528900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transvascular delivery of small interfering RNA to the central nervous system.
    Kumar P; Wu H; McBride JL; Jung KE; Kim MH; Davidson BL; Lee SK; Shankar P; Manjunath N
    Nature; 2007 Jul; 448(7149):39-43. PubMed ID: 17572664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and Characterization of siRNA-Loaded Liposomes.
    Liu Y; Huang L
    Methods Mol Biol; 2021; 2282():159-169. PubMed ID: 33928575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A designed recombinant fusion protein for targeted delivery of siRNA to the mouse brain.
    Haroon MM; Dar GH; Jeyalakshmi D; Venkatraman U; Saba K; Rangaraj N; Patel AB; Gopal V
    J Control Release; 2016 Apr; 228():120-131. PubMed ID: 26948382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma.
    Grafals-Ruiz N; Rios-Vicil CI; Lozada-Delgado EL; Quiñones-Díaz BI; Noriega-Rivera RA; Martínez-Zayas G; Santana-Rivera Y; Santiago-Sánchez GS; Valiyeva F; Vivas-Mejía PE
    Int J Nanomedicine; 2020; 15():2809-2828. PubMed ID: 32368056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoformulation of Apolipoprotein E3-Tagged Liposomal Nanoparticles for the co-Delivery of KRAS-siRNA and Gemcitabine for Pancreatic Cancer Treatment.
    Wang F; Zhang Z
    Pharm Res; 2020 Nov; 37(12):247. PubMed ID: 33216236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoplexes Strengthened by Anionic Polymers: Easy Preparation of Highly Effective siRNA Vectors Based on Cationic Lipids and Anionic Polymers.
    Arruda DC; Schlegel A; Bigey P; Escriou V
    Methods Mol Biol; 2016; 1445():137-48. PubMed ID: 27436316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.
    Dos Santos Rodrigues B; Lakkadwala S; Kanekiyo T; Singh J
    Int J Nanomedicine; 2019; 14():6497-6517. PubMed ID: 31616141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of siRNA into the blood-brain barrier: recent advances and future perspective.
    Kuwahara H; Yokota T
    Ther Deliv; 2012 Apr; 3(4):417-20. PubMed ID: 22834073
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex.
    Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H
    J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Going beyond the liver: progress and challenges of targeted delivery of siRNA therapeutics.
    Lorenzer C; Dirin M; Winkler AM; Baumann V; Winkler J
    J Control Release; 2015 Apr; 203():1-15. PubMed ID: 25660205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy.
    Dorrani M; Garbuzenko OB; Minko T; Michniak-Kohn B
    J Control Release; 2016 Apr; 228():150-158. PubMed ID: 26965957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifunctional, self-assembling anionic peptide-lipid nanocomplexes for targeted siRNA delivery.
    Tagalakis AD; Lee DH; Bienemann AS; Zhou H; Munye MM; Saraiva L; McCarthy D; Du Z; Vink CA; Maeshima R; White EA; Gustafsson K; Hart SL
    Biomaterials; 2014 Sep; 35(29):8406-15. PubMed ID: 24985735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonviral pulmonary delivery of siRNA.
    Merkel OM; Kissel T
    Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.